Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

25.27
-0.3800-1.48%
Volume:591.20K
Turnover:15.01M
Market Cap:2.23B
PE:-5.77
High:25.86
Open:25.68
Low:24.95
Close:25.65
52wk High:47.65
52wk Low:14.53
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.64
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:4.04
PE(LYR):-11.03

Loading ...

Mineralys CMO David Malcom Rodman disposes of 417 shares for $11,491.35

Reuters
·
May 20

Guggenheim Keeps Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS)

TIPRANKS
·
May 19

Mineralys presents Phase 3 Launch-HTN lorundrostat data in hypertension, CKD at ESH 2026

Reuters
·
May 19

BRIEF-Mineralys Therapeutics Announces Presentation Of New Data From The Late-Stage Launch-Htn Trial Of Lorundrostat

Reuters
·
May 19

Mineralys Therapeutics Announces Presentation of New Data From the Phase 3 Launch-Htn Trial of Lorundrostat at the 35TH European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

THOMSON REUTERS
·
May 19

Mineralys CMO David Malcom Rodman disposes of shares worth $648,330.57

Reuters
·
May 14

Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Context Therapeutics (CNTX)

TIPRANKS
·
May 07

Mineralys Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 07

Earnings Flash (MLYS) Mineralys Therapeutics Posts Q1 EPS -$0.47, vs. FactSet Est of -$0.47

MT Newswires Live
·
May 07

Mineralys Therapeutics Q1 EPS USD -0.47

THOMSON REUTERS
·
May 07

Mineralys Q1 FY26 net loss narrows to $39.3 million; G&A expenses climb to $21 million

Reuters
·
May 07

Mineralys Therapeutics Inc - FDA Accepts Nda for Lorundrostat in Hypertension With Pdufa Date December 22, 2026

THOMSON REUTERS
·
May 07

BRIEF-Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
May 06

Mineralys grants inducement equity awards totaling 52,080 shares to two new hires

Reuters
·
May 06

Mineralys Therapeutics to join Bank of America Securities Health Care Conference fireside chat

Reuters
·
May 05

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

GlobeNewswire
·
May 05

Mineralys Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Apr 27

Mineralys Therapeutics initiated with a Buy at TD Cowen

TIPRANKS
·
Apr 27

Mineralys CMO David Malcom Rodman disposes of USD 13,033 Mineralys shares

Reuters
·
Apr 22

Mineralys CMO David Malcom Rodman sells USD 541,129 of common shares

Reuters
·
Apr 16